- Home
- NNBR vs KRRO Comparison
NNBR vs KRRO Comparison
Compare NNBR & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNBR
- KRRO
- Stock Information
- Founded
- NNBR 1980
- KRRO 2014
- Country
- NNBR United States
- KRRO United States
- Employees
- NNBR N/A
- KRRO N/A
- Industry
- NNBR Industrial Machinery/Components
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- NNBR Industrials
- KRRO Health Care
- Exchange
- NNBR Nasdaq
- KRRO Nasdaq
- Market Cap
- NNBR 111.0M
- KRRO 101.4M
- IPO Year
- NNBR 1994
- KRRO 2019
- Fundamental
- Price
- NNBR $1.97
- KRRO $12.35
- Analyst Decision
- NNBR
- KRRO Strong Buy
- Analyst Count
- NNBR 0
- KRRO 7
- Target Price
- NNBR N/A
- KRRO $85.67
- AVG Volume (30 Days)
- NNBR 215.6K
- KRRO 203.4K
- Earning Date
- NNBR 08-06-2025
- KRRO 08-12-2025
- Dividend Yield
- NNBR N/A
- KRRO N/A
- EPS Growth
- NNBR N/A
- KRRO N/A
- EPS
- NNBR N/A
- KRRO N/A
- Revenue
- NNBR $448,780,000.00
- KRRO $4,821,000.00
- Revenue This Year
- NNBR N/A
- KRRO $65.08
- Revenue Next Year
- NNBR $4.96
- KRRO N/A
- P/E Ratio
- NNBR N/A
- KRRO N/A
- Revenue Growth
- NNBR N/A
- KRRO N/A
- 52 Week Low
- NNBR $1.58
- KRRO $10.29
- 52 Week High
- NNBR $4.67
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- NNBR 47.29
- KRRO 41.55
- Support Level
- NNBR $1.82
- KRRO $11.50
- Resistance Level
- NNBR $2.10
- KRRO $16.86
- Average True Range (ATR)
- NNBR 0.15
- KRRO 1.50
- MACD
- NNBR -0.02
- KRRO 0.01
- Stochastic Oscillator
- NNBR 26.79
- KRRO 31.35
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.